Find uplifting stories about heroes, innovations, and solutions
18 results for "novartis"
A newly tested Novartis drug successfully reduced inflammation markers that contribute to heart disease, bringing hope for better cardiovascular treatments. Higher doses showed even stronger results, proving the medicine works as designed.
A new state-of-the-art cancer treatment facility is coming to Denton, Texas, bringing cutting-edge radioligand therapy closer to patients across the Southern United States. The 46,000-square-foot plant will create hundreds of specialized jobs while expanding access to revolutionary cancer care.
A groundbreaking RNA therapy just succeeded in early trials for a rare muscular dystrophy affecting thousands, and it could become the first treatment that actually modifies the disease's progression. Novartis's del-brax showed clear signs of reducing muscle damage in patients with facioscapulohumeral muscular dystrophy.
Major pharmaceutical and medical technology companies are building their artificial intelligence centers in Hyderabad, transforming the Indian city into a global innovation powerhouse. Companies like Novartis, Takeda, and Amgen are developing cutting-edge AI tools and decision-making platforms from the city that now serve their worldwide operations.
A pharmaceutical company in Malaysia just won a major tech award for an AI assistant that answers employee questions in 120 languages, day or night. What used to take days now happens in seconds.
Isomorphic Labs is about to test the first drugs designed by Nobel Prize-winning AI technology in human patients. The breakthrough could transform how we discover safer, more effective medicines for diseases like cancer.
St. Bernards Healthcare just became the only hospital in Northeast Arkansas offering a targeted therapy for rare digestive cancers. The treatment delivers precision radiation directly to tumors, giving patients as young as 12 a new option when traditional therapies fail.
Belgium just approved its first medicine through a groundbreaking fast-track system that reimburses promising treatments before full European authorization. Patients with a rare kidney disease no longer have to wait months for access to life-changing medicine.
When Nishant Chaturvedi lost his pharmaceutical role during restructuring, he became his son's primary caregiver while his wife's career flourished. His journey is reshaping what modern fatherhood looks like in India.
A new targeted therapy for chronic myeloid leukemia achieved major molecular responses in nearly half of patients with advanced disease. The drug, ELVN-001, performed even better in patients treated earlier, offering fresh hope in the fight against this slow-growing blood cancer.
The scientist who won a Nobel Prize for predicting protein structures is now using that breakthrough to design new medicines for diseases once thought untreatable. His lab has 17 drugs in development and expects to start human trials by year's end.
Demis Hassabis just secured $2.1 billion to accelerate AI-designed medicines that could transform how we treat and cure diseases. The first human trials are expected by the end of 2026.
Scientists at MIT discovered a natural protein in our gut that both strengthens our protective mucus layer and kills dangerous bacteria, including strains that resist antibiotics. This breakthrough could lead to entirely new treatments for gut diseases and drug-resistant infections.
The U.S. government just named 15 more medications, including treatments for HIV, arthritis, and diabetes, that will see lower prices through Medicare negotiations starting in 2028. The move is expected to save billions while making essential medications more affordable for seniors and people with disabilities.
A new medical trust fund in Ghana has already helped 33 people afford critical cancer treatment, with plans to expand nationwide next year. The program focuses on expensive, high-burden cancers and aims to train 100 specialized nurses to support patients across the country.
The Supreme Court rejected challenges from six major drug companies, allowing Medicare to negotiate lower prescription prices for millions of Americans. This landmark decision marks a major victory for affordable healthcare.
Adults with a rare genetic disease called cystinosis no longer need dozens of pills each day after receiving a groundbreaking one-time gene therapy. Five years later, most patients show stable or improved health across multiple organs.
Brunei just became the first country to use artificial intelligence to predict and prevent heart disease across its entire population. The program could save thousands of lives and serve as a model for nations worldwide.